HEALTH CATALYST INC (HCAT)
US42225T1079 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to HCAT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 12.1. This target is 116.34% above the current price.
HCAT was analyzed by 23 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about HCAT.
In the previous month the buy percentage consensus was at a similar level.
HCAT was analyzed by 23 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-10 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-04-10 | Keybanc | Downgrade | Overweight -> Sector Weight |
| 2024-03-05 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-02-26 | Keybanc | Maintains | Overweight -> Overweight |
| 2024-02-23 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-02-23 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-02-23 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-01-26 | Guggenheim | Upgrade | Neutral -> Buy |
| 2024-01-03 | Evercore ISI Group | Upgrade | In-Line -> Outperform |
| 2023-12-22 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-12-13 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2023-11-13 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2023-11-01 | Stifel | Maintains | Hold -> Hold |
| 2023-10-30 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2023-09-14 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-29 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2023-08-01 | Cantor Fitzgerald | Initiate | Overweight -> Overweight |
| 2023-05-10 | Guggenheim | Downgrade | Buy -> Hold |
| 2023-05-10 | RBC Capital | Maintains | Sector Perform |
| 2023-05-10 | Raymond James | Downgrade | Strong Buy -> Market Perform |
| 2023-04-20 | Keybanc | Upgrade | Sector Weight -> Overweight |
| 2023-04-04 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2023-03-24 | Citigroup | Maintains | Buy |
| 2023-03-08 | Citigroup | Maintains | Buy |
| 2023-03-07 | Wells Fargo | Maintains | Equal-Weight |
| 2023-03-02 | Raymond James | Maintains | Strong Buy |
| 2023-03-01 | RBC Capital | Maintains | Sector Perform |
| 2023-01-03 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2022-11-10 | Raymond James | Maintains | Strong Buy |
| 2022-11-09 | SVB Leerink | Maintains | Outperform |